| 000 | 01304 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516100002.0 | ||
| 264 | 0 | _c20140606 | |
| 008 | 201406s 0 0 eng d | ||
| 022 | _a1875-8584 | ||
| 024 | 7 |
_a10.3233/BEN-2012-120267 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPidgeon, Connie | |
| 245 | 0 | 0 |
_aThe pathophysiology and pharmacological treatment of Huntington disease. _h[electronic resource] |
| 260 |
_bBehavioural neurology _c2013 |
||
| 300 |
_a245-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review; Systematic Review | ||
| 650 | 0 | 4 |
_aAntidepressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBasal Ganglia _xdrug effects |
| 650 | 0 | 4 |
_aCannabinoids _xtherapeutic use |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xtherapeutic use |
| 650 | 0 | 4 |
_aGABA Agonists _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHuntington Disease _xdrug therapy |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aTetrabenazine _xtherapeutic use |
| 700 | 1 | _aRickards, Hugh | |
| 773 | 0 |
_tBehavioural neurology _gvol. 26 _gno. 4 _gp. 245-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3233/BEN-2012-120267 _zAvailable from publisher's website |
| 999 |
_c21878010 _d21878010 |
||